These findings underline the value of iPSC‐derived motor neurons as a preclinical model for ALS/FTD and highlight the therapeutic potential of HDAC6 inhibitors for TDP‐43 proteinopathies. The gene discussed is HDAC6; the disease is amyotrophic lateral sclerosis.